These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 30084297)

  • 1. Analyzing pre-post randomized studies with one post-randomization score using repeated measures and ANCOVA models.
    Wan F
    Stat Methods Med Res; 2019; 28(10-11):2952-2974. PubMed ID: 30084297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analyzing pre-post designs using the analysis of covariance models with and without the interaction term in a heterogeneous study population.
    Wan F
    Stat Methods Med Res; 2020 Jan; 29(1):189-204. PubMed ID: 30757963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statistical analysis of two arm randomized pre-post designs with one post-treatment measurement.
    Wan F
    BMC Med Res Methodol; 2021 Jul; 21(1):150. PubMed ID: 34303343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized clinical trials with a pre- and a post-treatment measurement: repeated measures versus ANCOVA models.
    Winkens B; van Breukelen GJ; Schouten HJ; Berger MP
    Contemp Clin Trials; 2007 Nov; 28(6):713-9. PubMed ID: 17524958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of covariance in randomized trials: More precision and valid confidence intervals, without model assumptions.
    Wang B; Ogburn EL; Rosenblum M
    Biometrics; 2019 Dec; 75(4):1391-1400. PubMed ID: 31009064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of covariance with pre-treatment measurements in randomized trials under the cases that covariances and post-treatment variances differ between groups.
    Funatogawa T; Funatogawa I; Shyr Y
    Biom J; 2011 May; 53(3):512-24. PubMed ID: 22223254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parametric versus non-parametric statistics in the analysis of randomized trials with non-normally distributed data.
    Vickers AJ
    BMC Med Res Methodol; 2005 Nov; 5():35. PubMed ID: 16269081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Robustness of ANCOVA in randomized trials with unequal randomization.
    Bartlett JW
    Biometrics; 2020 Sep; 76(3):1036-1038. PubMed ID: 31823345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Robustness of response-adaptive randomization.
    Ye X; Hu F; Ma W
    Biometrics; 2024 Mar; 80(2):. PubMed ID: 38819309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The correlation between baseline score and post-intervention score, and its implications for statistical analysis.
    Clifton L; Clifton DA
    Trials; 2019 Jan; 20(1):43. PubMed ID: 30635021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of percentage change from baseline as an outcome in a controlled trial is statistically inefficient: a simulation study.
    Vickers AJ
    BMC Med Res Methodol; 2001; 1():6. PubMed ID: 11459516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of covariance with pre-treatment measurements in randomized trials: comparison of equal and unequal slopes.
    Funatogawa I; Funatogawa T
    Biom J; 2011 Sep; 53(5):810-21. PubMed ID: 21887795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ANCOVA versus change from baseline: more power in randomized studies, more bias in nonrandomized studies [corrected].
    Van Breukelen GJ
    J Clin Epidemiol; 2006 Sep; 59(9):920-5. PubMed ID: 16895814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bias, precision and statistical power of analysis of covariance in the analysis of randomized trials with baseline imbalance: a simulation study.
    Egbewale BE; Lewis M; Sim J
    BMC Med Res Methodol; 2014 Apr; 14():49. PubMed ID: 24712304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The analysis of cross-over trials with baseline measurements.
    Metcalfe C
    Stat Med; 2010 Dec; 29(30):3211-8. PubMed ID: 21170915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the repeated measures designs and sample sizes for randomized controlled trials.
    Tango T
    Biostatistics; 2016 Apr; 17(2):334-49. PubMed ID: 26586845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small-sample performance and underlying assumptions of a bootstrap-based inference method for a general analysis of covariance model with possibly heteroskedastic and nonnormal errors.
    Zimmermann G; Pauly M; Bathke AC
    Stat Methods Med Res; 2019 Dec; 28(12):3808-3821. PubMed ID: 30600769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The optimal pre-post allocation for randomized clinical trials.
    Ma S; Wang T
    BMC Med Res Methodol; 2023 Mar; 23(1):72. PubMed ID: 36978004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Propensity score weighting for covariate adjustment in randomized clinical trials.
    Zeng S; Li F; Wang R; Li F
    Stat Med; 2021 Feb; 40(4):842-858. PubMed ID: 33174296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conditional estimation and inference to address observed covariate imbalance in randomized clinical trials.
    Zhang Z; Tang L; Liu C; Berger VW
    Clin Trials; 2019 Apr; 16(2):122-131. PubMed ID: 30444129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.